Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-2 of 2
Keywords: Immunoblastic lymphoma
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Robert Pirker, Josef D Schwarzmeier, Thaddaeus Radaszkiewicz, Reinhard Lenzhofer, Klaus Konrad, Peter Bettelheim, Kurt Bauer, Friedrich Prischl
Journal:
Acta Haematologica
Acta Haematol (1986) 75 (2): 105–109.
Published Online: 25 February 2009
...Robert Pirker; Josef D Schwarzmeier; Thaddaeus Radaszkiewicz; Reinhard Lenzhofer; Klaus Konrad; Peter Bettelheim; Kurt Bauer; Friedrich Prischl We present a female patient with a B-immunoblastic lymphoma of the IgM-A type arising in angioimmunoblastic lymphadenopathy. An increased ratio of helper...
Journal Articles
Journal:
Acta Haematologica
Acta Haematol (1985) 74 (3): 175–177.
Published Online: 25 February 2009
...Arturo Pereira; Francisco Cervantes; Nuria Viñolas; Carlos Llebaría; Juan Pedro-Botet; Ciril Rozman Immunoblastic lymphoma developed in a patient diagnosed as having angioimmunoblastic lymphadenopathy 5 years earlier. Chemotherapy schedules including alkylating agents were administered for 1 year...
